|Bid||70.90 x 1200|
|Ask||70.91 x 1100|
|Day's Range||70.54 - 71.51|
|52 Week Range||60.10 - 85.00|
|Beta (5Y Monthly)||1.18|
|PE Ratio (TTM)||9.09|
|Earnings Date||Nov 01, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||85.83|
Subscribe to Yahoo Finance Plus to view Fair Value for HOLXLearn more
ATLANTA, October 19, 2021--A multidisciplinary group of experts agree that elevating awareness of a woman’s period as a vital sign of health would help to routinize and prioritize care for the uterine fibroids that impact eighty percent of Black women1. This approach was one of several key initiatives proposed to reduce disparities in uterine fibroid care during Unmuting Fibroids: Getting Loud for Equal Care, a roundtable convened by The Black Women’s Health Imperative (BWHI) in partnership with
Hologic (HOLX) closed at $70.02 in the latest trading session, marking a +0.5% move from the prior day.
Hologic's (HOLX) recent acquisition will accelerate its growth and enhance patient outcomes by leveraging significant commercial resources and strong relationships with OB/GYN specialists.